Adriana Maria Montano Suarez

Title: Innovations of Adriana Maria Montano Suarez

Introduction

Adriana Maria Montano Suarez is a notable inventor based in St. Louis, MO (US). She has made significant contributions to the field of enzyme replacement therapy, particularly in addressing metabolic disorders. With a total of 2 patents, her work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

One of her latest patents is focused on prenatal enzyme replacement therapy for hypophosphatasia. This innovative approach involves administering a pharmaceutical composition that includes a water-soluble tissue-nonspecific alkaline phosphatase (TNSALP) to a pregnant animal. The therapy aims to restore normal metabolic activity in the fetus by allowing the protein to cross the placenta and enter the fetal bloodstream. Another significant patent enhances the effect of therapeutic proteins on the central nervous system. This invention involves a polypeptide therapeutic agent that improves enzyme replacement therapy outcomes by attaching a short acidic amino acid sequence to human β-glucuronidase. This method is particularly useful in treating type VII mucopolysaccharidosis.

Career Highlights

Adriana is affiliated with Saint Louis University, where she continues her research and development in enzyme replacement therapies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

She has collaborated with esteemed colleagues such as William S. Sly and Jeffrey H. Grubb, contributing to a rich environment of innovation and discovery.

Conclusion

Adriana Maria Montano Suarez is a pioneering inventor whose work in enzyme replacement therapy is making a significant difference in the medical field. Her innovative patents and collaborations highlight her dedication to improving health outcomes for patients with metabolic disorders.